Grief Is Born When Fertility Drugs Don’t Deliver
When it comes to conception, modern technology doesn’t always eclipse Mother Nature. Infertile women are opening up about the shame of childlessness in an age of high-tech babies.
Author
Alizah Salario
Alizah Salario's Latest Articles
Teen Moms Get ‘No Stigma, No Shame’ Pep Talk
In a retort to a New York City subway ad campaign last year criticized for shaming teen moms, a Bronx female politician recently told a gathering of young mothers about her own path out of the shame and stigma that still surrounds teen motherhood.
Retail Manager Stressed by ‘Never Enough’ Sales Strategy
Connie Larson is taking time off so her feet can heal, which means no pay and paying out of pocket. Beyond her own problems, she worries about the sales and commission quotas she is supposed to enforce. “It’s a fear-based situation,” she says.
Anti-Sex Trade Turns to Focus on Men Who Buy Sex
A legal shift in looking at the men who pay for sex is a new focus for anti-sex trafficking activists. The strategy has led to changes in state legislation and educational programs at a growing number of “john schools.”
Lap-Band Complications Could Tie Up Nation’s E.R.
The FDA’s recent expansion of gastric-banding weight-loss surgery to millions more Americans could burden the nation’s E.R. with complications that patients discuss in online forums, such as vomiting and abdominal pain. The third of three stories.
FDA Asked to Rein in ‘Get Slim’ Surgery Ads
Southern California billboard ads are criticized for their casual portrayal of Lap-Band weight-loss surgery in light of recent deaths linked to the surgery. On Feb. 16 the FDA approved the surgery for lower weight people.
Lap-Band Critics Decry Excess Rhetoric on Weight
New Year’s resolutions put weight loss at the top of many to-do lists. But that doesn’t mean more people should be seriously thinking about bariatric surgery, say critics of a recent FDA advisory ruling on the weight-loss implant.
FDA Panel’s OK for Lap-Band Surgery Stirs Critics
Women’s health advocates are unhappy about a FDA advisory panel’s support last week for increasing the eligibility scope of a weight-reduction implant used by far more women than men. They say the risks are too clear and the data too limited.
